[{"address1": "890 Winter Street", "address2": "Suite 200", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 208 2466", "website": "https://upstreambio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Aaron  Deykin M.D.", "age": 57, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 736700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. E. Rand Sutherland M.D., M.P.H., MPH", "age": 53, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael Paul Gray CPA, MBA", "age": 52, "title": "CFO & COO", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Parika  Petaipimol M.S.", "title": "Head of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Fiering", "title": "Senior Vice President of People & Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam  Houghton M.B.A., Ph.D.", "age": 53, "title": "Chief Business Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mersedeh  Miraliakbari Pharm.D.", "title": "Senior Vice President of Regulatory Affairs & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Fang  Xie Ph.D.", "title": "VP & Head of Biometrics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sumathi  Sivapalasingam M.D.", "title": "VP & Head of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maryse  Courval M.S.", "title": "VP & Head of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 22.74, "open": 22.45, "dayLow": 17.8101, "dayHigh": 23.36, "regularMarketPreviousClose": 22.74, "regularMarketOpen": 22.45, "regularMarketDayLow": 17.8101, "regularMarketDayHigh": 23.36, "forwardPE": -7.7991023, "volume": 455532, "regularMarketVolume": 455532, "averageVolume": 419257, "averageVolume10days": 214160, "averageDailyVolume10Day": 214160, "bid": 17.83, "ask": 18.08, "bidSize": 100, "askSize": 100, "marketCap": 965274752, "fiftyTwoWeekLow": 17.8101, "fiftyTwoWeekHigh": 29.46, "priceToSalesTrailing12Months": 437.36963, "fiftyDayAverage": 25.025715, "twoHundredDayAverage": 25.025715, "currency": "USD", "enterpriseValue": 1127430784, "floatShares": 29007016, "sharesOutstanding": 53596600, "sharesShort": 230692, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0121, "heldPercentInsiders": 0.19253, "heldPercentInstitutions": 0.61288, "shortRatio": 0.16, "impliedSharesOutstanding": 53596600, "bookValue": -52.987, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -69589000, "trailingEps": -1.36, "forwardEps": -2.37, "enterpriseToRevenue": 510.843, "enterpriseToEbitda": -17.155, "52WeekChange": 0.03363633, "SandP52WeekChange": 0.2977997, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "UPB", "underlyingSymbol": "UPB", "shortName": "Upstream Bio, Inc.", "longName": "Upstream Bio, Inc.", "firstTradeDateEpochUtc": 1728653400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "8c021aef-709a-354f-aca6-53250e396496", "messageBoardId": "finmb_1773603947", "gmtOffSetMilliseconds": -18000000, "currentPrice": 18.01, "targetHighPrice": 75.0, "targetLowPrice": 38.0, "targetMeanPrice": 56.5, "targetMedianPrice": 56.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 220659008, "totalCashPerShare": 4.117, "ebitda": -65722000, "totalDebt": 1941000, "quickRatio": 20.393, "currentRatio": 20.901, "totalRevenue": 2207000, "debtToEquity": 0.88, "revenuePerShare": 0.771, "operatingCashflow": -55670000, "revenueGrowth": -0.023, "grossMargins": 1.0, "operatingMargins": -31.12521, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-21"}]